tariquidar has been researched along with technetium tc 99m sestamibi in 3 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (technetium tc 99m sestamibi) | Trials (technetium tc 99m sestamibi) | Recent Studies (post-2010) (technetium tc 99m sestamibi) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 5,774 | 627 | 1,208 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, SF; Chen, C; Figg, WD; Fojo, T; Kang, M; Robey, R | 1 |
| Abraham, J; Agrawal, M; Balis, FM; Bates, S; Chen, CC; Edgerly, M; Fojo, T; Stein, WD | 1 |
| Blumenschein, G; Boniface, G; Booser, D; Fleming, DR; Hortobagyi, GN; Ibrahim, N; Pusztai, L; Rivera, E; Rouzier, R; Symmans, FW; Theriault, R; Wagner, P; Wong, F | 1 |
1 review(s) available for tariquidar and technetium tc 99m sestamibi
| Article | Year |
|---|---|
Reversal of multidrug resistance: lessons from clinical oncology.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Clinical Trials as Topic; Cyclosporins; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms; Piperidines; Pyridines; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured | 2002 |
2 trial(s) available for tariquidar and technetium tc 99m sestamibi
| Article | Year |
|---|---|
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Resistance, Neoplasm; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Vinblastine; Vinorelbine | 2003 |
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Quinolines; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2005 |